MedTrace Logo

Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal Cancers

NCT01023529 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2015-11-18

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of palliative pelvic radiation on symptoms and quality of life among patients with incurable prostate and rectal cancer.

Conditions

  • Prostatic Neoplasms
  • Rectal Neoplasms

Interventions

RADIATION

Palliative pelvic soft-tissue radiation (external beam)

3 Gy x 10-13 (range 30 - 39 Gy total)

Sponsors & Collaborators

  • Oslo University Hospital

    collaborator OTHER

  • Sykehuset Innlandet HF

    collaborator OTHER

  • Nordlandssykehuset HF

    collaborator OTHER

  • University Hospital of North Norway

    collaborator OTHER

  • Helse Stavanger HF

    collaborator OTHER_GOV

  • Alesund Hospital

    collaborator OTHER

  • Trondheim University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    lead OTHER_GOV

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01023529 on ClinicalTrials.gov